- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2023–2028 · cooperative agreement · U01
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
Srinivas Raghavan Viswanathan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · research · R01
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
Mohammad Rashidian · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · program · P50
Biostatistics/Computational Core
Svitlana Tyekucheva · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Research Project 1: Diffuse Midline Glioma
Daphne A. Haas-Kogan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · program · P50
Developmental Research Program
Matthew L Freedman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · program · P50
Dissecting and Predicting Lethal Prostate Cancer using Biologically Informed Artificial Intelligence
Eliezer M Van Allen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Cross-Training Core (ROBIN-NEST)
Ross I. Berbeco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Administrative Core
Daphne A. Haas-Kogan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · program · P50
Biospecimen Core
Mark M. Pomerantz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Shared Resource Core 2: Clinical Artificial Intelligence Core
Danielle S Bitterman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Shared Resource Core 1: Molecular Data Science and Advanced Dosimetry
Franziska Michor · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · program · P50
DF/HCC Prostate SPORE
Himisha Beltran · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · program · P50
Molecular Determinants of Response and Resistance to EZH2 and PARP inhibition in Prostate Cancer
Himisha Beltran · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Molecular Characterization Trial
David Kozono · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · program · P50
Efficacy and Mechanisms of Resistance to Neoadjuvant Intensive Androgen Signaling Inhibition
Mary-Ellen Taplin · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · program · P50
Career Enhancement Program
Himisha Beltran · Dana-Farber Cancer Institute · funded by National Institutes of Health
2023–2028 · cooperative agreement · U54
Research Project 2: Neuroblastoma
Dipanjan Chowdhury · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2026 · award
Quality of End-of-Life Care for Children with Cancer: Can we Measure It Across Diverse Populations
Emily Johnston · Dana-Farber Cancer Institute · funded by American Cancer Society
2022–2027 · cooperative agreement · U24
Generating a full-length reference transcriptome for human protein-coding genes
David E. Hill · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · research · R01
Elucidating the molecular mechanism and physiological relevance of TIRR mediated inhibition of p53
Dipanjan Chowdhury · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2024 · award
Harnessing Geospatial Data for Precision Prevention of Prostate Cancer
Hari Iyer · Dana-Farber Cancer Institute · funded by American Cancer Society
2022–2026 · grant · PRCRP
Precision Targeting of Cell Cycle Checkpoints in TP53-Mutant Endometrial Cancer
Sarah Hill · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2022–2024 · research · R21
Sleep Treatment Education Program-1 (STEP-1): A Randomized Trial of a Self-Management Insomnia Intervention for Cancer Survivors
Christopher John Recklitis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2026 · grant · KCRP
Deep Functional Characterization of MiT/TFE Fusions in Translocation Renal Cell Carcinoma
Srinivas Viswanathan · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2022–2025 · research · R00
Mechanistic characterization of the anti-inflammatory function of thermogenic fat for the treatment of metabolic disorders
Evanna Louisa Mills · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · research · R01
Tissue-based biomarkers of anti-PD-1-based therapy in metastatic renal cell carcinoma
Toni Choueiri · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2023 · fellowship · Career Development Award
Defining mechanisms of succinate-mediated muscle adaptation to exercise in skeletal myopathy induced by heart failure
Luiz Henrique Marchesi Bozi · Dana-Farber Cancer Institute · funded by American Heart Association
2022–2027 · research · R01
Engineering dendritic cells to target islet antigen to pro-tolerogenic subsets for prevention and treatment of Type 1 Diabetes
Judith Agudo Cantero · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
Altered metabolism and machine learning for pancreatic cancer early detection
Michael H. Rosenthal · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · career development · K08
Diversifying Acute Leukemia Clinical Trial Enrollment Through Multilevel Intervention
Andrew Hantel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2026 · award
A research program to promote cancer care equity for incarcerated and recently incarcerated individuals in the United States
Christopher Manz · Dana-Farber Cancer Institute · funded by American Cancer Society
2022–2027 · award
Developing Precision Therapies for Lung Cancer
Pasi Janne · Dana-Farber Cancer Institute · funded by American Cancer Society
2022–2024 · award
(Copy Of) Disparities in Uptake of Novel Therapies and Guideline-Concordant Care for Patients with Acute Myeloid Leukemia
Gregory Abel · Dana-Farber Cancer Institute · funded by American Cancer Society
2022–2029 · research · R35
Molecular Prediction of Myeloma Initiation Molecular Prediction of Myeloma Initiation
Irene M. Ghobrial · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · research · R01
Targeting Nucleotide Excision Repair Deficiency to Improve Bladder Sparing Treatment for Muscle Invasive Bladder Cancer
Kent W Mouw · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · program · P01
Mechanisms and Therapy of Chronic Graft-vs.-Host Disease
Corey S Cutler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · career development · K08
Tracing the Evolution of Chronic Lymphocytic Leukemia to Richter's Syndrome: Defining Transformation
Erin M Parry · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · research · R01
Elucidating the molecular mechanism and physiological relevance of TIRR mediated inhibition of p53
Dipanjan Chowdhury · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
Molecular prediction of myeloma in African Americans
Irene M. Ghobrial · Dana-Farber Cancer Institute · funded by National Institutes of Health
2022–2025 · research · R21
STEP-YA: An Online Self-Management Intervention for Young Adult Cancer Survivors with Insomnia
Christopher John Recklitis · Dana-Farber Cancer Institute · funded by National Institutes of Health
